Picture of 4Basebio logo

4BB 4Basebio Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+28.85%
3m+71.1%
6m+157.08%
1yr+186.63%
Volume Change (%)
10d/3m+70.29%
Price vs... (%)
52w High-1.4%
50d MA+41.19%
200d MA+116.72%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-83.48%
Return on Equity-231.29%
Operating Margin-1591.3%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of 4Basebio EPS forecast chart

Profile Summary

4basebio PLC is a United Kingdom-based specialist life sciences company. It is focused on therapeutic deoxyribonucleic (DNA) for cell and gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. It is engaged in the manufacturing and supplying of application specific synthetic DNA for research, therapeutic and pharmacological use and develop non-viral vectors for the efficient delivery of payloads. It has technology in the fields of DNA synthesis and payload delivery, which enables it to manufacture both synthetic DNA constructs and messenger ribonucleic acid (mRNA) and develop vectors for cell and tissue-specific delivery for a range of applications. Its applications include AAV and Lentivirus viral vectors; mRNA vaccines and therapeutics, Genome editing; DNA vaccines, and Hermes non-viral delivery. It is also focused on exploiting intellectual property in the field of cell and gene therapies and DNA vaccines.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    December 22nd, 2020
    Public Since
    February 17th, 2021
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    12,805,208

    4BB Share Price Performance

    Latest News for 4BB

    Upcoming Events for 4BB

    4Basebio PLC Annual Shareholders Meeting

    4Basebio PLC Company Presentation

    Half Year 2025 4Basebio PLC Earnings Release

    Similar to 4BB

    Picture of Allergy Therapeutics logo

    Allergy Therapeutics

    gb flag iconLondon Stock Exchange

    Picture of Arecor Therapeutics logo

    Arecor Therapeutics

    gb flag iconLondon Stock Exchange

    Picture of Avacta logo

    Avacta

    gb flag iconLondon Stock Exchange

    Picture of Batm Advanced Communications logo

    Batm Advanced Communications

    gb flag iconLondon Stock Exchange

    Picture of Bioventix logo

    Bioventix

    gb flag iconLondon Stock Exchange

    FAQ